- Home
- FLY vs ACLX Comparison
FLY vs ACLX Comparison
Compare FLY & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLY | ACLX |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | 1409 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.7B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | FLY | ACLX |
|---|---|---|
| Price | $40.19 | $115.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $38.88 | ★ $118.17 |
| AVG Volume (30 Days) | 8.3M | ★ 12.1M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,286,000.00 |
| Revenue This Year | $174.79 | $342.39 |
| Revenue Next Year | $66.73 | $170.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.00 | $60.36 |
| 52 Week High | $62.17 | $115.14 |
Technical Indicators
Market Signals| Indicator | FLY | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 79.86 |
| Support Level | $18.95 | $63.46 |
| Resistance Level | $48.28 | N/A |
| Average True Range (ATR) | 5.36 | 0.11 |
| MACD | -0.82 | -0.62 |
| Stochastic Oscillator | 9.31 | 84.28 |
Price Performance
Historical ComparisonAbout FLY Firefly Aerospace Inc.
Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.